Telesis Bio Inc (TBIO)
0.92
-0.05
(-5.15%)
USD |
OTCM |
Nov 14, 15:59
Telesis Bio Shareholders Equity (Quarterly): 9.946M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 9.946M |
March 31, 2024 | 21.65M |
December 31, 2023 | 29.54M |
September 30, 2023 | 46.49M |
June 30, 2023 | 56.07M |
March 31, 2023 | 36.62M |
December 31, 2022 | 46.56M |
September 30, 2022 | 53.31M |
Date | Value |
---|---|
June 30, 2022 | 64.72M |
March 31, 2022 | 78.10M |
December 31, 2021 | 90.78M |
September 30, 2021 | 102.76M |
June 30, 2021 | 112.44M |
March 31, 2021 | -32.70M |
December 31, 2020 | -25.46M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-32.70M
Minimum
Mar 2021
112.44M
Maximum
Jun 2021
46.06M
Average
46.56M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
Standard BioTools Inc | 489.33M |
Ainos Inc | 20.71M |
Zomedica Corp | 208.72M |
LENSAR Inc | 23.64M |
Intelligent Bio Solutions Inc | 8.329M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 52.73M |
Total Liabilities (Quarterly) | 42.78M |
Debt to Equity Ratio | 0.5307 |
Current Ratio | 1.891 |
Net Debt Paydown Yield | 44.78% |